Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/17056720

Proc. Natl. Acad. Sci. U.S.A. 2006 Oct 31 103 44 16436-41

Download in:

View as

Triples

General Info

PMID
17056720